Publications by authors named "Zelda Euler"

Claim this Profile
U
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trial.
Valentin Voillet, Janine van Duijn, Kanika Vanshylla, One B Dintwe, Laura Pattacini, Zelda Euler

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute quantitation of binding antibodies from clinical samples.
Chan Tang, Annemiek Verwilligen, Jerald Sadoff, Boerries Brandenburg, Eveline Sneekes-Vriese, Zelda Euler

NPJ Vaccines· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound.
Rasmus Offersen, Wen-Han Yu, Eileen P Scully, Boris Julg, Zelda Euler

Cell Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users.
Zelda Euler, Tom L VAN DEN Kerkhof, Roger D Kouyos, Damien C Tully, Todd M Allen

Viruses· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Dan H Barouch, Frank L Tomaka, Frank Wegmann, Daniel J Stieh, Galit Alter, Zelda Euler

Lancet· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
Marion Cornelissen, Zelda Euler, Tom L G M van den Kerkhof, Marit J van Gils, Brigitte D M Boeser-Nunnink

AIDS Res Hum Retroviruses· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies.
Jenniffer M Mabuka, Anne-Sophie Dugast, Daniel M Muema, Tarylee Reddy, Yathisha Ramlakhan, Zelda Euler

Front Immunol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
Laura E McCoy, Emilia Falkowska, Katie J Doores, Khoa Le, Devin Sok, Zelda Euler

PLoS Pathog· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
Katarzyna Kaczmarek Michaels, Malini Natarajan, Zelda Euler, Galit Alter, Gregory Viglianti

J Immunol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.
Zelda Euler, Galit Alter

AIDS Res Hum Retroviruses· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers.
Tom L G M van den Kerkhof, Zelda Euler, Marit J van Gils, Brigitte D Boeser-Nunnink, Hanneke Schuitemaker

AIDS· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.
Tom L G M van den Kerkhof, K Anton Feenstra, Zelda Euler, Marit J van Gils, Linda W E Rijsdijk

Retrovirology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.
Zelda Euler, Marit J van Gils, Brigitte D Boeser-Nunnink, Hanneke Schuitemaker, Daniëlle van Manen

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
Hugo Mouquet, Louise Scharf, Zelda Euler, Yan Liu, Caroline Eden

Proc Natl Acad Sci U S A· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactive broadly neutralizing antibodies: timing is everything.
Zelda Euler, Hanneke Schuitemaker

Front Immunol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of CD4 binding site antibodies during HIV-1 infection.
Rebecca M Lynch, Lillian Tran, Mark K Louder, Stephen D Schmidt, Myron Cohen, Zelda Euler

J Virol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.
Nicolas Ruffin, Marie Borggren, Zelda Euler, Fabio Fiorino, Katrijn Grupping

J Transl Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.
Zelda Euler, Tom L G M van den Kerkhof, Marit J van Gils, Judith A Burger, Diana Edo-Matas

J Virol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
Vincent A de Weger, Annelies W Turksma, Quirinus J M Voorham, Zelda Euler, Herman Bril

Clin Cancer Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
Zelda Euler, Evelien M Bunnik, Judith A Burger, Brigitte D M Boeser-Nunnink, Marlous L Grijsen

J Virol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.
Evelien M Bunnik, Zelda Euler, Matthijs R A Welkers, Brigitte D M Boeser-Nunnink, Marlous L Grijsen

Nat Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.
Zelda Euler, Marit J van Gils, Evelien M Bunnik, Pham Phung, Becky Schweighardt

J Infect Dis· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.
Marit J van Gils, Zelda Euler, Becky Schweighardt, Terri Wrin, Hanneke Schuitemaker

AIDS· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis